Enrolling in Medicare Advantage for 2026? Make Sure to Avoid These Big Mistakes.

With fall Medicare open enrollment closing in roughly a week, beneficiaries must finalize 2026 coverage choices; moving from original Medicare to Medicare Advantage can provide an annual out-of-pocket cap and supplemental benefits (dental, vision, hearing, fitness, meal delivery) but typically restricts provider networks. Investors and advisors should note common plan trade-offs—frequently advertised $0 premiums may be offset by higher copays/deductibles—and should weigh provider network inclusion, actual usability of supplemental benefits, total expected costs, and Medicare's annually updated star ratings when assessing potential enrollee flows and insurer competitiveness.

Analysis

Market structure: Medicare Advantage enrollment pressure (open enrollment window closing) favors large, vertically integrated MA carriers (UNH, HUM, CVS/ELV) and ancillary vendors (dental, vision, DME providers) that monetize supplemental benefits. Small regional carriers, independent hospitals and fee‑for‑service specialists face margin pressure as MA plans push narrower networks and cap OOP exposure — expect 100–300bps share migration toward national MA leaders over 2–3 years if current trends persist. Cross‑asset: stronger insurer cashflows are modestly positive for IG credit spreads and could reduce defensive demand for long‑duration Treasuries; sectors: healthcare defensives outperform cyclicals in a risk‑off move.

Risk assessment: Key tail risks are sudden CMS reimbursement changes or star‑rating downgrades that trigger membership churn (single‑event downside 10–20% EPS hit for exposed plans). Immediate (days): enrollment flows and plan selection data can cause sentiment swings; short‑term (weeks/months): membership guidance into Q4/Q1 earnings; long‑term (years): structural MA penetration and regulatory clampdowns. Hidden dependencies include provider contract renegotiations, telehealth adoption in rural cohorts, and actual utilization of supplemental benefits which could swing margins ±200–500bps. Catalysts: CMS enrollment prints (Dec–Feb), CMS proposed rules (Jan–Mar), major insurer earnings and 2026 rate announcements.

Trade implications: Direct: establish 2–4% long positions in UNH and HUM (scale 50% now, 50% on pullback >5%); size 1–2% long in CVS/ELV for PBM/retail leverage. Pair: long UNH / short HCA (1–1 exposure) to capture insurer margin expansion vs hospital revenue pressure over 6–18 months. Options: buy 6–9 month UNH vertical call spreads (buy 1–2% OTM, sell 6–8% OTM) to limit premium; for HUM consider buying Jan 2026 3–4% OTM calls after Dec enrollment print. Entry/Exit: initiate into Dec–Jan enrollment data, trim 50% on strong Jan earnings or if CMS proposes adverse rule; stop loss at 12% drawdown.

Contrarian angles: Consensus underestimates operational leverage inside MA plans from reduced churn and higher ancillary take rates — a 3‑5ppt uptake in dental/vision utilization can add several dollars of EBITDA per member. Conversely, the market may be underpricing regulatory risk: a downgrade of star ratings across a major plan (drop ≥1 star) remains a low‑probability, high‑impact event capable of 15–25% downside for that carrier. Historical parallel: managed‑care consolidation in the 2000s produced multi‑year outperformance for scale players; monitor two triggers — CMS star rating changes and quarter‑over‑quarter MA net membership swings >0.5% — as early indicators to accelerate or reverse positions.

Key Decisions for Investors

• Establish a 2–4% long position in UnitedHealth (UNH), scaling 50% now and 50% on a pullback >5%; complement with a 6–9 month bull call spread (buy 2% OTM, sell 8% OTM) sized at 0.5–1% of portfolio to capture upside while limiting premium.
• Add a 2% long position in Humana (HUM) for pure MA exposure and buy Jan 2026 3–4% OTM calls (0.5% portfolio) after Dec enrollment prints if net new MA membership > consensus, otherwise wait.
• Initiate a pair trade: long UNH vs short HCA (dollar‑neutral, 1:1) sized 1–2% of portfolio to exploit margin squeeze on hospitals; close or rebalance if HCA outperforms by >8% or UNH falls >12%.
• Reduce/avoid exposure (>50% trim) to mid/small regional insurers and standalone hospital operators if CMS issues adverse payment guidance in Jan–Mar or if a plan loses ≥1 star in next CMS rating release; redeploy proceeds into large MA carriers or IG healthcare credit.